AstraZeneca to Begin Supplying COVID-19 Vaccine in September

AstraZeneca Plc. plans to make over 30 million doses available in the United kingdom as early as September.



AstraZeneca-Coronavirus-COVID-Vaccine

New Cambridge R&D Centre and Global HQ (Image: AstraZeneca Plc)

The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes as planned, the drug maker will make first deliveries starting September 1.

A smaller part of the COVID-19 vaccine trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older. The larger stage will test the coronavirus vaccine’s effectiveness in volunteers 18 and older.

Pharmaceutical companies across the globe are in a race against time to develop an effective COVID-19 vaccine. A lot of these manufacturers are doing it for no profit.

COVID-19 Vaccine Production

AstraZeneca recently got a boost in its efforts to get the vaccine tested and ready for use when the United States pledged $1.2 billion on Thursday.

Adult subjects for the trial will be randomly chosen to receive one or two doses of the Oxford candidate or a licensed vaccine against meningococcus for comparison.

Volunteers will be recruited across the United Kingdom and will record their reactions in a journal as well as attend follow-up visits. Some of the volunteers will also be given swabs for taking samples at home.

This COVID-19 vaccine is made from a weakened version of a common cold virus that’s genetically modified to make it unable to grow in the human body. Over 1,000 volunteers have already received the coronavirus vaccine during an early-stage trial that began in April.

AstraZeneca Plc. plans to make over 30 million doses available in the United Kingdom as early as September. Meanwhile, the United States could begin receiving the COVID-19 vaccine as early as October.

A challenge for all of humanity  

AstraZeneca will be producing coronavirus vaccine in more than one country. The pharmaceutical company thanked the US and UK governments for significant support to accelerate the development and production of the COVID vaccine.

The drugmaker is also in discussions with the Serum Institute of India and other potential partners to increase COVID-19 vaccine production.

AstraZeneca said it is capable of producing one billion doses of the COVID vaccine this year and next. The company will make “every effort we can deliver these doses at no profit while at the same time working on parallel supply chains to supply the world.”

AstraZeneca CEO Pascal Soriot described the global coronavirus pandemic as a “global tragedy” and a “challenge for all of humanity.”

 

Whether you want to stay up-to-date on the latest business news, read in-depth CEO interviews, or find new ideas on leadership, management and innovation, Industry Leaders Magazine is here to suit your needs and help you stay more informed.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Who is Parag Agrawal, Twitter’s new CEO?

Who is Parag Agrawal, Twitter’s new CEO?

Indian-born Parag Agrawal took over as the CEO of Twitter as co-founder Jack Dorsey stepped down for the second time in his career. Agrawal is the fourth person to take the reins a
3 hours ago
Goldman Sachs rolls out paid leave for pregnancy loss

Goldman Sachs rolls out paid leave for pregnancy loss

Goldman employees are now eligible for 20 days of paid leave for a miscarriage or stillbirth. The investment banking giant is also increasing its retirement fund matching contribut
4 hours ago
Boom in Tech IPOs in 2021

Boom in Tech IPOs in 2021

The big tech cloud-based software companies such as Zoom, Snowflake, Asana, Airbnb, Amazon, Salesforce and Palantir have all witnessed a rise in stock prices as work from home and
23 hours ago
Walmart is Shopping for a New CFO

Walmart is Shopping for a New CFO

Walmart Inc. announced that they are looking for a new chief financial officer to replace Brett Biggs, who will begin transitioning from Walmart this year, after 22 years with the
1 day ago
Petrobras of Brazil Revises Expenditure on Oil Exploration and Production to $68 Billion

Petrobras of Brazil Revises Expenditure on Oil Exploration and Production to $68 Billion

“As long as there is a need, Petrobras will be [there] because of its efficiency and low carbon content,” Joaquim Silva e Luna, chief executive, Petrobras.
2 days ago
IPOs Stumbling in Face of High Valuations

IPOs Stumbling in Face of High Valuations

More than half of the companies that raised more than $1 billion for initial public offerings are now trading way below their listing price.
2 days ago